Irinotecan and bevacizumab in recurrent glioblastoma multiforme

Authors:

Abstract
(2011). Irinotecan and bevacizumab in recurrent glioblastoma multiforme. Expert Opinion on Pharmacotherapy: Vol. 12, No. 5, pp. 825-833. doi: 10.1517/14656566.2011.566558

This publication has 76 references indexed in Scilit: